# Nadolol Versus Propranolol in Children With Infantile Hemangiomas

> **NCT02505971** · PHASE3 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 74 (actual)

## Conditions studied

- Infantile Hemangioma

## Interventions

- **DRUG:** Nadolol
- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT02505971
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2020-04
- **Final completion:** 2020-06-30
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505971, "Nadolol Versus Propranolol in Children With Infantile Hemangiomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02505971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*